These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 26897940)
21. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer. Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811 [TBL] [Abstract][Full Text] [Related]
22. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195 [TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of ANO9 in stage II and III colorectal carcinoma. Li C; Cai S; Wang X; Jiang Z Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine. Liu M; Xu A; Yuan X; Zhang Q; Fang T; Wang W; Li C J Transl Med; 2015 Jun; 13():195. PubMed ID: 26084278 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
26. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729 [TBL] [Abstract][Full Text] [Related]
27. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL; Chen LM; Wang WM; Zhang LM Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779 [TBL] [Abstract][Full Text] [Related]
28. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360 [TBL] [Abstract][Full Text] [Related]
29. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. Sun B; Yang M; Li M; Wang F Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer. Huang Y; Xiao W; Jiang X; Li H Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145 [TBL] [Abstract][Full Text] [Related]
31. Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro. Lv Y; Shi Y; Han Q; Dai G Mol Med Rep; 2017 Oct; 16(4):4437-4444. PubMed ID: 28765946 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
33. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism. Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795 [TBL] [Abstract][Full Text] [Related]
35. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer. Zou G; Wang R; Wang M Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664 [TBL] [Abstract][Full Text] [Related]
36. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer. Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-223 functions as an oncogene in human colorectal cancer cells. Zhang J; Luo X; Li H; Yue X; Deng L; Cui Y; Lu Y Oncol Rep; 2014 Jul; 32(1):115-20. PubMed ID: 24819398 [TBL] [Abstract][Full Text] [Related]
38. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer. Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
40. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer. Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]